Home Healthcare Biotechnology Cancer Microbiome Sequencing Market

Cancer Microbiome Sequencing Market Size, Share & Trends Analysis Report By Offering (Product, Service), By Application (Translational Research and Diagnostics), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction), By End-User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR1824DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Cancer Microbiome Sequencing Market, By Offering 2022-2034 (USD MILLION/ Units)
    1. Product
      1. Kits
      2. Assays
      3. Software
    2. Service
  2. Cancer Microbiome Sequencing Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Translational Research and Diagnostics
      1. Colorectal Cancer
      2. Cervical Cancer
      3. Oral Cancer
      4. Other Cancer Types
  3. Cancer Microbiome Sequencing Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Next-Generation Sequencing
      1. Sequencing by Synthesis
      2. Sequencing by Ligation
      3. Other Next-Generation Sequencing Technologies
    2. Polymerase Chain Reaction
  4. Cancer Microbiome Sequencing Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Academic and Research Institutes
    2. Pharmaceutical and Biotechnology Companies
    3. Hospitals and Diagnostic Laboratories
  5. Regional Cancer Microbiome Sequencing Market
    1. North America
      1. North America Cancer Microbiome Sequencing Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
      2. North America Cancer Microbiome Sequencing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
      3. North America Cancer Microbiome Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        2. Polymerase Chain Reaction
      4. North America Cancer Microbiome Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutes
        2. Pharmaceutical and Biotechnology Companies
        3. Hospitals and Diagnostic Laboratories
      5. U.S.
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      6. Canada
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
    2. Europe
      1. Europe Cancer Microbiome Sequencing Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
      2. Europe Cancer Microbiome Sequencing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
      3. Europe Cancer Microbiome Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        2. Polymerase Chain Reaction
      4. Europe Cancer Microbiome Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutes
        2. Pharmaceutical and Biotechnology Companies
        3. Hospitals and Diagnostic Laboratories
      5. U.K.
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      6. Germany
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      7. France
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      8. Spain
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      9. Italy
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      10. Russia
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      11. Nordic
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      12. Benelux
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      13. Rest of Europe
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
    3. APAC
      1. APAC Cancer Microbiome Sequencing Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
      2. APAC Cancer Microbiome Sequencing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
      3. APAC Cancer Microbiome Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        2. Polymerase Chain Reaction
      4. APAC Cancer Microbiome Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutes
        2. Pharmaceutical and Biotechnology Companies
        3. Hospitals and Diagnostic Laboratories
      5. China
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      6. Korea
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      7. Japan
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      8. India
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      9. Australia
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      10. Taiwan
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      11. South East Asia
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      12. Rest of Asia-Pacific
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
    4. Middle East and Africa
      1. Middle East and Africa Cancer Microbiome Sequencing Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
      2. Middle East and Africa Cancer Microbiome Sequencing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
      3. Middle East and Africa Cancer Microbiome Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        2. Polymerase Chain Reaction
      4. Middle East and Africa Cancer Microbiome Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutes
        2. Pharmaceutical and Biotechnology Companies
        3. Hospitals and Diagnostic Laboratories
      5. UAE
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      6. Turkey
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      7. Saudi Arabia
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      8. South Africa
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      9. Egypt
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      10. Nigeria
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      11. Rest of MEA
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
    5. LATAM
      1. LATAM Cancer Microbiome Sequencing Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
      2. LATAM Cancer Microbiome Sequencing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
      3. LATAM Cancer Microbiome Sequencing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        2. Polymerase Chain Reaction
      4. LATAM Cancer Microbiome Sequencing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Academic and Research Institutes
        2. Pharmaceutical and Biotechnology Companies
        3. Hospitals and Diagnostic Laboratories
      5. Brazil
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      6. Mexico
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      7. Argentina
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      8. Chile
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      9. Colombia
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
      10. Rest of LATAM
        1. Product
          1. Kits
          2. Assays
          3. Software
        2. Service
        3. Translational Research and Diagnostics
          1. Colorectal Cancer
          2. Cervical Cancer
          3. Oral Cancer
          4. Other Cancer Types
        4. Next-Generation Sequencing
          1. Sequencing by Synthesis
          2. Sequencing by Ligation
          3. Other Next-Generation Sequencing Technologies
        5. Polymerase Chain Reaction
        6. Academic and Research Institutes
        7. Pharmaceutical and Biotechnology Companies
        8. Hospitals and Diagnostic Laboratories
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.